171 related articles for article (PubMed ID: 28093271)
1. Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.
Dixon EP; King LM; Nelson R; Simkins SG; Knapp SL; Brough GH; Lenz KL; Henderson DT; Whitehead CM; Hessling J; Brown CA; Malinowski DP
J Immunol Methods; 2017 Mar; 442():35-41. PubMed ID: 28093271
[TBL] [Abstract][Full Text] [Related]
2. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology.
Shroyer KR; Homer P; Heinz D; Singh M
Cancer; 2006 Oct; 108(5):324-30. PubMed ID: 16937378
[TBL] [Abstract][Full Text] [Related]
3. A cocktail of MCM2 and TOP2A, p16INK4a and Ki-67 as biomarkers for the improved diagnosis of cervical intraepithelial lesion.
Yang QC; Zhu Y; Liou HB; Zhang XJ; Shen Y; Ji XH
Pol J Pathol; 2013 Apr; 64(1):21-7. PubMed ID: 23625596
[TBL] [Abstract][Full Text] [Related]
4. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
Aximu D; Azad A; Ni R; Colgan T; Nanji S
Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
[TBL] [Abstract][Full Text] [Related]
5. The selection and characterization of antibodies to minichromosome maintenance proteins that highlight cervical dysplasia.
Henderson D; Hall L; Prpic N; Hessling J; Parker M; Sampson S; Simkins S; Brough G; Dixon E; Lenz K; Knapp S; Murphy P; Taylor A; Fischer T; Malinowski DP
J Immunol Methods; 2011 Jul; 370(1-2):1-13. PubMed ID: 21601573
[TBL] [Abstract][Full Text] [Related]
6. MCM2/TOP2A (ProExC) immunohistochemistry as a predictive marker in head and neck mucosal biopsies.
Jenson EG; Baker M; Paydarfar JA; Gosselin BJ; Li Z; Black CC
Pathol Res Pract; 2014 Jun; 210(6):346-50. PubMed ID: 24630889
[TBL] [Abstract][Full Text] [Related]
7. [Expression of ProEXC, p16 and Ki-67 in cervical intraepithelial lesion by immunohistochemistry: diagnostic and clinical significance].
Yang QC; Liu HB; Zhu Y; Zhang XJ; Shen Y; Ji XH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):405-7. PubMed ID: 22932410
[No Abstract] [Full Text] [Related]
8. Demonstration of an epitope of the transferrin receptor in human cervical epithelium--a potentially useful cell marker.
Lloyd JM; O'Dowd T; Driver M; Tee DE
J Clin Pathol; 1984 Feb; 37(2):131-5. PubMed ID: 6198338
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical patterns of ProEx C in vulvar squamous lesions: detection of overexpression of MCM2 and TOP2A.
Chen H; Gonzalez JL; Brennick JB; Liu M; Yan S
Am J Surg Pathol; 2010 Sep; 34(9):1250-7. PubMed ID: 20697251
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.
Halloush RA; Akpolat I; Jim Zhai Q; Schwartz MR; Mody DR
Cancer; 2008 Dec; 114(6):474-80. PubMed ID: 19016301
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of Ca antigen in normal, dysplastic and neoplastic squamous epithelia of the human uterine cervix.
Lloyd JM; O'Dowd T; Driver M; Tee DE
J Clin Pathol; 1984 Jan; 37(1):14-9. PubMed ID: 6368596
[TBL] [Abstract][Full Text] [Related]
12. ProEx™ C is a useful ancillary study for grading anal intraepithelial neoplasia alone and in combination with other biomarkers.
Larson BK; Mohanty SK; Wu JM; Bose S; Walts AE
APMIS; 2016 Mar; 124(3):175-80. PubMed ID: 26590011
[TBL] [Abstract][Full Text] [Related]
13. ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review.
Botti G; Malzone MG; La Mantia E; Montanari M; Vanacore D; Rossetti S; Quagliariello V; Cavaliere C; Di Franco R; Castaldo L; Ametrano G; Cappuccio F; Romano FJ; Piscitelli R; Pepe MF; D'Aniello C; Facchini G
Int J Med Sci; 2017; 14(6):554-559. PubMed ID: 28638271
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical analysis of the cervical Pap smear.
Morgan TK; Berlin M
Methods Mol Biol; 2015; 1249():203-12. PubMed ID: 25348308
[TBL] [Abstract][Full Text] [Related]
15. Is the expression pattern of BD ProExC the same as Ki-67? A comparative analysis in cervical biopsies.
Walts AE; Bose S
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):262-7. PubMed ID: 19875954
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of p16 and TOP2A protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania.
Zuberi Z; Mremi A; Chilongola JO; Semango G; Sauli E
PLoS One; 2021; 16(10):e0259096. PubMed ID: 34705880
[TBL] [Abstract][Full Text] [Related]
17. Expression of ProEx C in primary and metastatic urothelial carcinoma.
Liu L; Cohen C; Siddiqui MT
Diagn Cytopathol; 2015 Mar; 43(3):181-7. PubMed ID: 24975746
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
Martens JE; Smedts F; ter Harmsel B; Helmerhorst TJ; Ramaekers FC
Anticancer Res; 1997; 17(6D):4305-9. PubMed ID: 9494525
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care.
Peres AL; Paz E Silva KM; de Araújo RF; de Lima Filho JL; de Melo Júnior MR; Martins DB; de Pontes Filho NT
J Biomed Sci; 2016 May; 23(1):42. PubMed ID: 27175798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]